http://www.ptcommunity.com/news/DailyDetail.cfm?chosen=69000
Teva Pharmaceutical Industries Ltd. has announced the launch of the generic equivalent to Baraclude (entecavir) tablets, 0.5 mg and 1.0 mg, in the U.S. Teva was the first to file, making the product eligible for 180 days of marketing exclusivity.
very good news prices should lower now